Health Tech Capitol | Uncategorized
1
archive,paged,category,category-uncategorized,category-1,paged-24,category-paged-24,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Uncategorized

Exact Sciences Corp. is adding an executive of Abbott Laboratories/AbbVie, one of the biggest U.S. pharmaceutical companies, to lead its Cologuard campaign. Exact created the position of president, Cologuard, for Mark Stenhouse; he will join Exact’s Madison headquarters on April 2. Stenhouse is vice president, U.S. Immunology...

Cellectar Biosciences has been granted orphan drug designation for its therapeutic, CLR 131, by the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development for the treatment of neuroblastoma, the company announced today. With the orphan drug designation, Cellectar Biosciences will receive seven-year market exclusivity benefits, increased...

Xconomy Wisconsin — An estimated 29.4 million adults in the U.S. suffer from sleep apnea, a major contributor to the “epidemic” of Americans not getting enough sleep, according to the Centers for Disease Control and Prevention. Sleep apnea—interruptions in breathing that can be caused by obstructions such as the tonsils—is a...